- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05604443
Keratoconus Detection Using MS39 and Pentacam (KKMS39Penta)
October 12, 2023 updated by: Johannes Kepler University of Linz
Keratoconus Detection Using MS39 and Pentacam - a Retrospective Study
This retrospective study aims to investigate whether the MS39 and Pentacam are delivering comparable results in the diagnosis of keratoconus.
In the future, these measurement devices could be interchangeable in usage.
Study Overview
Detailed Description
Keratoconus is a degenerative pathology of the cornea, which tends to progress.
It comes along with central and paracentral thinning of the cornea as well as with an apical protrusion of the cornea.
Keratoconus leads to vision loss.
This pathology is diagnosed by using CE certified OCT technology in order to map the topography of the cornea.
This process constitutes a really important step in the line of management of the keratoconus.
MS39 and Pentacam are used for detection.
Retrospectively, data will be investigated, in order to see if these measurement devices deliver comparable results.
In the future, these measurement devices could be interchangeable in usage.
Study Type
Observational
Enrollment (Actual)
173
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nino Hirnschall, MD
- Phone Number: 1048 +435768083
- Email: nino.hirnschall@kepleruniklinikum.at
Study Contact Backup
- Name: Matthias Bolz, MD
- Phone Number: 1050 +4357680883
- Email: matthias.bolz@kepleruniklinikum.at
Study Locations
-
-
Oberösterreich
-
Linz, Oberösterreich, Austria, 4020
- Department for Ophthalmology and Optometry, Kepler University Hospital GmbH, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 100 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
patients between 14 and 100 years who consult Keratokonus specialst.
Description
Inclusion Criteria:
- age older than 14 years
- patients who show up at Keratokonus consultation hours
Exclusion Criteria:
- age younger than 14 years
- age older than 100 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
topography of the cornea
Time Frame: 12 months
|
measurement of the topography of the cornea with MS39 and Pentacam
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Matthias Bolz, MD, JKU Linz
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 28, 2022
Primary Completion (Actual)
April 1, 2023
Study Completion (Actual)
May 1, 2023
Study Registration Dates
First Submitted
October 5, 2022
First Submitted That Met QC Criteria
November 2, 2022
First Posted (Actual)
November 3, 2022
Study Record Updates
Last Update Posted (Actual)
October 13, 2023
Last Update Submitted That Met QC Criteria
October 12, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KUK-Ophthalmology-007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Keratoconus
-
The Cleveland ClinicUniversity of MarylandEnrolling by invitationKeratoconus | Keratoconus, Unstable | Keratoconus, StableUnited States
-
Eye Hospital Pristina KosovoActive, not recruitingKeratoconus | Keratoconus of Right Eye | Keratoconus, Unstable, Right EyeKosovo
-
Tianjin Eye HospitalRecruitingScansys, Pentacam, Keratoconus, Subclinical KeratoconusChina
-
Tianjin Eye HospitalActive, not recruitingScansys, Pentacam, Corvis ST, Keratoconus, Subclinical KeratoconusChina
-
Heba Allah Nashaat MohamedAssiut UniversityRecruitingKeratoconus, CollagenEgypt
-
Kent Wellish MDNot yet recruitingKeratoconus, Unstable
-
Kasr El Aini HospitalUnknownProgressive KeratoconusEgypt
-
Centre Hospitalier Régional Metz-ThionvilleCompletedProgressive Keratoconus
-
Glaukos CorporationCompletedProgressive KeratoconusUnited States
-
Tianjin Eye HospitalCompletedKeratoconus, StableChina
Clinical Trials on retrospective analyze
-
University Hospital, Strasbourg, FranceQuantmetryUnknown
-
Fundació Institut de Recerca de l'Hospital de la...Completed
-
Novartis PharmaceuticalsCompletedCardiovascular Disease and Lipoprotein(a)China, Germany, United States, Colombia, South Africa, Italy, Spain, Belgium, Egypt, Hungary, Taiwan, Turkey, Japan, Netherlands, Australia, Austria, Canada, Czechia, France, Israel, Switzerland, United Kingdom, Korea, Republic of, Th... and more
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI); Canadian Institutes of Health... and other collaboratorsTerminatedHeart ArrestUnited States, Canada
-
Abbott Medical DevicesCompleted
-
Sanford HealthUniversity of North DakotaCompletedStroke, AcuteUnited States
-
University of LuebeckRecruiting
-
Hospices Civils de LyonRecruiting
-
Weill Medical College of Cornell UniversityActive, not recruitingInfertility | ART | in Vitro Fertilization (IVF)United States
-
Fundación Canaria Rafael Clavijo para la Investigación...UnknownPatients Admitted With the Diagnosis of ST-elevation Acute Coronary SyndromeSpain